Evaluation of Xpert MTB/RIF Assay for Diagnosis of Tuberculosis in Children

J Trop Pediatr. 2019 Feb 1;65(1):14-20. doi: 10.1093/tropej/fmy005.

Abstract

Introduction: Childhood tuberculosis (TB) is now a global priority. With the advent of Xpert MTB/RIF, more TB cases in children are being reported. This study was undertaken to evaluate the performance of Xpert in diagnosis of pulmonary and extra-pulmonary TB in children.

Methods: Specimens from 171 suspected TB cases in children aged <15 years were tested with Xpert, culture and smear microscopy in the Department of Microbiology, Institute of Medical Sciences, India.

Results: The specimens included 106 gastric aspirates, 51 cerebrospinal fluids, 8 induced sputum and 6 lymph node aspirates. Xpert detected Mycobacterium tuberculosis in 19 cases (14 pulmonary and 5 extra-pulmonary), 7 of which were rifampicin-resistant. Sensitivity, specificity, positive predictive value and negative predictive value of Xpert compared with culture were 88.89, 98.04, 84.21 and 98.68%, respectively. The sensitivity was 100% in children aged 1-5 years and 6-10 years and in gastric aspirates.

Conclusion: Xpert is an efficient diagnostic tool in childhood tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Child, Preschool
  • DNA, Bacterial / isolation & purification
  • Female
  • Gastric Juice / microbiology*
  • Humans
  • India
  • Male
  • Molecular Diagnostic Techniques / methods*
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / isolation & purification*
  • Predictive Value of Tests
  • Rifampin / pharmacology
  • Rifampin / therapeutic use*
  • Sensitivity and Specificity
  • Sequence Analysis, DNA / methods
  • Sputum / microbiology*
  • Tuberculosis / diagnosis*
  • Tuberculosis, Pulmonary / diagnosis*

Substances

  • DNA, Bacterial
  • Rifampin